CAY10703

CAY10703

CAT N°: 18911
Price:

From 48.00 40.80

Dichloroacetate (DCA) is an inhibitor of all pyruvate dehydrogenase kinase (PDHK) isoforms, which are enzymes that phosphorylate and inhibit PDH in mitochondria.{30579,30576} Inhibition of PDHK shifts cell metabolism from glycolysis to mitochondrial glucose oxidation, an effect that has relevance to cancer, type 2 diabetes, and other diseases.{30576,30577} CAY10703 is a DCA trimer that is at least 10-fold more cytotoxic against leukemia cell lines than DCA.{30578} It is approximately 3-fold less cytotoxic than DCA against peripheral blood mononuclear cells from healthy blood donors. CAY10703 significantly reduces both basal and maximal respiration in leukemia cells.{30578} It is stable in vivo after subcutaneous inoculation, remaining in circulation for more than five hours after injection.{30578}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N,N’,N”-(nitrilotris(ethane-2,1-diyl))tris(2,2-dichloroacetamide)
  • Correlated keywords
    • CAY 10703 dichloroacetate derivative DCA trimer cytotoxic leukemia
  • Product Overview:
    Dichloroacetate (DCA) is an inhibitor of all pyruvate dehydrogenase kinase (PDHK) isoforms, which are enzymes that phosphorylate and inhibit PDH in mitochondria.{30579,30576} Inhibition of PDHK shifts cell metabolism from glycolysis to mitochondrial glucose oxidation, an effect that has relevance to cancer, type 2 diabetes, and other diseases.{30576,30577} CAY10703 is a DCA trimer that is at least 10-fold more cytotoxic against leukemia cell lines than DCA.{30578} It is approximately 3-fold less cytotoxic than DCA against peripheral blood mononuclear cells from healthy blood donors. CAY10703 significantly reduces both basal and maximal respiration in leukemia cells.{30578} It is stable in vivo after subcutaneous inoculation, remaining in circulation for more than five hours after injection.{30578}

We also advise you